Megan Lord

Associate Professor

Megan Lord is Associate Professor of Biomedical Engineering and Director of the Molecular Surface Interaction Network Laboratory at UNSW.

Associate Professor Lord has a Doctor of Philosophy in Engineering, Master of Biomedical Engineering and First class Honours degree in Chemical Engineering from UNSW. She publishes widely in biomaterials and extracellular matrix biochemistry with a focus on vascular applications. Her research has been supported by a number of grants including a prestigious Australian Research Council Postdoctoral Fellowship (2010-2012). She has published over 80 peer-reviewed scholarly articles and delivered invited keynote lectures in Australia and internationally.

Associate Professor Lord serves on the Standards Australia committee HE-030 Biological and Clinical Evaluation of Medical Devices that reviews and ratifies the International Standard ISO 10993 and TC 194. She is the President of the Matrix Biology Society of Australia and New Zealand. In 2014, Associate Professor Lord was named a NSW Young Tall Poppy by the Australian Institute of Policy and Science.

Associate Professor Lord's research is interdisciplinary combining the fields of biomaterials and extracellular matrix biochemistry with a focus on vascular applications and utilises her expertise on the analysis of dynamic interactions between cells, proteins and biomaterials. She utilises biomimetic approaches to develop biomaterials that effectively interface with the vasculature for applications as anticoagulant therapies, blood component storage, vascular grafts, soft tissue repair such as diabetic wounds and targeting the vasculature for cancer drug delivery therapy. She collaborates widely with industry and international academic institutions and is driven to make novel contributions to science that will benefit society. 

Associate Professor Lord has a track record of research student training having supervised to completion 16 PhD, 5 Masters by Research, 2 Bachelor of Medical Science (Honours) and over 130 Engineering thesis students. She currently leads a team of 14 researchers across the post-doctoral, doctoral and undergraduate levels.

 

PhD/Masters positions available. Associate Professor Lord is seeking talented candidates to work with her to understand how glycopolymers interact with the blood vessel interface, an extracellular matrix at the surface of endothelial cells. These findings have implications for the discovery of effective treatments for vascular complications associated with conditions such as diabetes and cancer.  This project is suited to candidates interested in developing their skills in biomaterials, biochemistry and biophysics and interested in working on a collaborative project with Synedgen Inc. An attractive scholarship package is available for domestic candidates who meet the eligibility criteria (Australian citizen or permanent resident and hold the equivalent of a First-class Honours degree in Engineering, Science or related field). Please contact Megan for more information.

 

More details at https://research.unsw.edu.au/people/associate-professor-megan-lord

 

Journal articles
add
Lau K; Waterhouse A; Akhavan B; Gao L; Kim HN; Tang F; Whitelock JM; Bilek MM; Lord MS; Rnjak-Kovacina J, 2021, 'Biomimetic silk biomaterials: Perlecan-functionalized silk fibroin for use in blood-contacting devices', Acta Biomaterialia, vol. 132, pp. 162 - 175, http://dx.doi.org/10.1016/j.actbio.2021.02.014
2021
Ng CY; Whitelock JM; Williams H; Kim HN; Medbury HJ; Lord MS, 2021, 'Macrophages bind LDL using heparan sulfate and the perlecan protein core', Journal of Biological Chemistry, vol. 296, pp. 100520, http://dx.doi.org/10.1016/j.jbc.2021.100520
2021
Chandrasekar K; Farrugia BL; Johnson L; Marks D; Irving D; Elgundi Z; Lau K; Kim HN; Rnjak-Kovacina J; Bilek MM; Whitelock JM; Lord MS, 2021, 'Effect of Recombinant Human Perlecan Domain V Tethering Method on Protein Orientation and Blood Contacting Activity on Polyvinyl Chloride', Advanced Healthcare Materials, vol. 10, http://dx.doi.org/10.1002/adhm.202100388
2021
Joukhdar H; Seifert A; Jüngst T; Groll J; Lord MS; Rnjak-Kovacina J, 2021, 'Ice Templating Soft Matter: Fundamental Principles and Fabrication Approaches to Tailor Pore Structure and Morphology and Their Biomedical Applications', Advanced Materials, vol. 33, http://dx.doi.org/10.1002/adma.202100091
2021
Lord MS; Berret JF; Singh S; Vinu A; Karakoti AS, 2021, 'Redox Active Cerium Oxide Nanoparticles: Current Status and Burning Issues', Small, http://dx.doi.org/10.1002/smll.202102342
2021
Liu J; Guo Z; Kordanovski M; Kaltbeitzel J; Zhang H; Cao Z; Gu Z; Wich PR; Lord M; Liang K, 2020, 'Metal-organic frameworks as protective matrices for peptide therapeutics', Journal of Colloid and Interface Science, vol. 576, pp. 356 - 363, http://dx.doi.org/10.1016/j.jcis.2020.05.057
2020
Lord M; Whitelock J; Turnbull JE, 2020, 'Better growth-factor binding aids tissue repair', Nature Biomedical Engineering, vol. 4, pp. 368 - 369, http://dx.doi.org/10.1038/s41551-020-0548-3
2020
Gao J; Wang WQ; Pei Q; Lord MS; Yu HJ, 2020, 'Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy', Acta Pharmacologica Sinica, vol. 41, pp. 986 - 994, http://dx.doi.org/10.1038/s41401-020-0400-z
2020
Bansal R; Elgundi Z; Care A; Goodchild SC; Lord MS; Rodger A; Sunna A, 2020, 'Elucidating the binding mechanism of a novel silica-binding peptide', Biomolecules, vol. 10, pp. 4 - 4, http://dx.doi.org/10.3390/biom10010004
2020
Bansal R; Elgundi Z; Goodchild SC; Care A; Lord MS; Rodger A; Sunna A, 2020, 'The effect of oligomerization on a solid-binding peptide binding to silica-based materials', Nanomaterials, vol. 10, pp. 1070 - 1070, http://dx.doi.org/10.3390/nano10061070
2020
Tang F; Manz XD; Bongers A; Odell RA; Joukhdar H; Whitelock JM; Lord MS; Rnjak-Kovacina J, 2020, 'Microchannels are an architectural cue that promotes integration and vascularization of silk biomaterials in vivo', ACS Biomaterials Science and Engineering, vol. 6, pp. 1476 - 1486, http://dx.doi.org/10.1021/acsbiomaterials.9b01624
2020
Lin X; Tang F; Jiang S; Khamis H; Bongers A; Whitelock JM; Lord MS; Rnjak-Kovacina J, 2020, 'A Biomimetic Approach toward Enhancing Angiogenesis: Recombinantly Expressed Domain V of Human Perlecan Is a Bioactive Molecule That Promotes Angiogenesis and Vascularization of Implanted Biomaterials', Adv. Sci., vol. 7, pp. 2000900, http://dx.doi.org/10.1002/advs.202000900
2020
Lord MS; Melrose J; Day AJ; Whitelock JM, 2020, 'The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology', Journal of Histochemistry and Cytochemistry, vol. 68, pp. 907 - 927, http://dx.doi.org/10.1369/0022155420940067
2020
Lau K; Akhavan B; Lord MS; Bilek MM; Rnjak-Kovacina J, 2020, 'Dry Surface Treatments of Silk Biomaterials and Their Utility in Biomedical Applications', ACS Biomaterials Science and Engineering, vol. 6, pp. 5431 - 5452, http://dx.doi.org/10.1021/acsbiomaterials.0c00888
2020
Gunawan C; Lord MS; Lovell E; Wong RJ; Jung MS; Oscar D; Mann R; Amal R, 2019, 'Oxygen-Vacancy Engineering of Cerium-Oxide Nanoparticles for Antioxidant Activity', ACS Omega, vol. 4, pp. 9473 - 9479, http://dx.doi.org/10.1021/acsomega.9b00521
2019
Dinoro J; Maher M; Talebian S; Jafarkhani M; Mehrali M; Orive G; Foroughi J; Lord MS; Dolatshahi-Pirouz A, 2019, 'Sulfated polysaccharide-based scaffolds for orthopaedic tissue engineering', Biomaterials, vol. 214, pp. 119214, http://dx.doi.org/10.1016/j.biomaterials.2019.05.025
2019
Bansal R; Care A; Lord MS; Walsh TR; Sunna A, 2019, 'Experimental and theoretical tools to elucidate the binding mechanisms of solid-binding peptides', New Biotechnology, vol. 52, pp. 9 - 18, http://dx.doi.org/10.1016/j.nbt.2019.04.001
2019
Farrugia BL; Mizumoto S; Lord MS; O’Grady RL; Kuchel RP; Yamada S; Whitelock JM, 2019, 'Hyaluronidase-4 is produced by mast cells and can cleave serglycin chondroitin sulfate chains into lower molecular weight forms', Journal of Biological Chemistry, vol. 294, pp. 11458 - 11472, http://dx.doi.org/10.1074/jbc.RA119.008647
2019
Thickett SC; Hamilton E; Yogeswaran G; Zetterlund PB; Farrugia BL; Lord MS, 2019, 'Enhanced osteogenic differentiation of human fetal cartilage rudiment cells on graphene oxide-PLGA hybrid microparticles', Journal of Functional Biomaterials, vol. 10, http://dx.doi.org/10.3390/jfb10030033
2019
Piloni A; Wong CK; Chen F; Lord M; Walther A; Stenzel MH, 2019, 'Surface roughness influences the protein corona formation of glycosylated nanoparticles and alter their cellular uptake', Nanoscale, vol. 11, pp. 23259 - 23267, http://dx.doi.org/10.1039/c9nr06835j
2019
Palmer JC; Green RA; Boscher F; Poole-Warren LA; Carter PM; Enke YL; Lovell NH; Lord MS, 2019, 'Development and performance of a biomimetic artificial perilymph for in vitro testing of medical devices', Journal of Neural Engineering, vol. 16, pp. 026006, http://dx.doi.org/10.1088/1741-2552/aaf482
2019
Lu M; Chen F; Cao C; Garvey CJ; Fletcher NL; Houston ZH; Lu H; Lord MS; Thurecht KJ; Stenzel MH, 2019, 'Importance of Polymer Length in Fructose-Based Polymeric Micelles for an Enhanced Biological Activity', Macromolecules, vol. 52, pp. 477 - 486, http://dx.doi.org/10.1021/acs.macromol.8b02381
2019
Lord M; Rnjak-Kovacina J; Tang F; Whitelock J, 2018, 'Glycosaminoglycan and Proteoglycan-Based Biomaterials: Current Trends and Future Perspectives', Advanced Healthcare Materials, vol. 7, pp. 1701042 - 1701042, http://dx.doi.org/10.1002/adhm.201701042
2018
Vassie JA; Whitelock JM; Lord MS, 2018, 'Targeted Delivery and Redox Activity of Folic Acid-Functionalized Nanoceria in Tumor Cells', Molecular Pharmaceutics, vol. 15, pp. 994 - 1004, http://dx.doi.org/10.1021/acs.molpharmaceut.7b00920
2018
Tang F; Lord M; Stallcup W; Whitelock J, 2018, 'Cell surface chondroitin sulfate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulfate proteoglycan, perlecan, and is involved in cell adhesion', The Journal of Biochemistry, vol. 163, pp. 399 - 412, http://dx.doi.org/10.1093/jb/mvy008
2018
Kondyurin A; Lau K; Tang F; Akhavan B; Chrzanowski W; Lord MS; Rnjak-Kovacina J; Bilek MM, 2018, 'Plasma Ion Implantation of Silk Biomaterials Enabling Direct Covalent Immobilization of Bioactive Agents for Enhanced Cellular Responses', ACS Applied Materials and Interfaces, vol. 10, pp. 17605 - 17616, http://dx.doi.org/10.1021/acsami.8b03182
2018
Farrugia BL; Lord MS; Whitelock JM; Melrose J, 2018, 'Harnessing chondroitin sulphate in composite scaffolds to direct progenitor and stem cell function for tissue repair', Biomaterials Science, vol. 6, pp. 947 - 957, http://dx.doi.org/10.1039/c7bm01158j
2018
Farrugia BL; Lord MS; Melrose J; Whitelock JM, 2018, 'The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies', Journal of Histochemistry and Cytochemistry, vol. 66, pp. 321 - 336, http://dx.doi.org/10.1369/0022155417740881
2018
Lord MS; Tang F; Rnjak-Kovacina J; Smith JGW; Melrose J; Whitelock JM, 2018, 'The multifaceted roles of perlecan in fibrosis', Matrix Biology, vol. 68-69, pp. 150 - 166, http://dx.doi.org/10.1016/j.matbio.2018.02.013
2018
Palmer JC; Lord MS; Pinyon JL; Wise AK; Lovell NH; Carter PM; Enke YL; Housley GD; Green RA, 2018, 'Comparing perilymph proteomes across species', Laryngoscope, vol. 128, pp. E47 - E52, http://dx.doi.org/10.1002/lary.26885
2018
Farrugia B; Mi Y; Kim HN; Whitelock J; Baker S; Wiesmann W; Li Z; Maitz P; Lord M, 2018, 'Chitosan‐Based Heparan Sulfate Mimetics Promote Epidermal Formation in a Human Organotypic Skin Model', Advanced Functional Materials, vol. 28, http://dx.doi.org/10.1002/adfm.201802818
2018
Lord MS; Ellis AL; Farrugia BL; Whitelock JM; Grenett H; Li C; O'Grady RL; DeCarlo AA, 2017, 'Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing', Journal of Controlled Release, vol. 250, pp. 48 - 61, http://dx.doi.org/10.1016/j.jconrel.2017.02.009
2017
Vassie JA; Whitelock JM; Lord MS, 2017, 'Endocytosis of cerium oxide nanoparticles and modulation of reactive oxygen species in human ovarian and colon cancer cells', Acta Biomaterialia, vol. 50, pp. 127 - 141, http://dx.doi.org/10.1016/j.actbio.2016.12.010
2017
Lord MS; Cheng B; Farrugia BL; McCarthy S; Whitelock JM, 2017, 'Platelet factor 4 binds to vascular proteoglycans and controls both growth factor activities and platelet activation', Journal of Biological Chemistry, vol. 292, pp. 4054 - 4063, http://dx.doi.org/10.1074/jbc.M116.760660
2017
Lord MS; Jung MS; Whitelock JM, 2017, 'Optimization of bioengineered heparin/heparan sulfate production for therapeutic applications', Bioengineered, vol. 8, pp. 661 - 664, http://dx.doi.org/10.1080/21655979.2017.1301328
2017
Kim HN; Whitelock JM; Lord MS, 2017, 'Structure-activity relationships of bioengineered heparin/heparan sulfates produced in different bioreactors', Molecules, vol. 22, http://dx.doi.org/10.3390/molecules22050806
2017
Rnjak-Kovacina J; Tang F; Lin X; Whitelock JM; Lord MS, 2017, 'Recombinant Domain V of Human Perlecan Is a Bioactive Vascular Proteoglycan', Biotechnology Journal, vol. 12, http://dx.doi.org/10.1002/biot.201700196
2017
Guo M; Lord MS; Peng Z, 2017, 'Quantitative wear particle analysis for osteoarthritis assessment', Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine, vol. 231, pp. 1116 - 1126, http://dx.doi.org/10.1177/0954411917735081
2017
Melrose J; Shu C; Whitelock JM; Lord MS, 2016, 'The cartilage extracellular matrix as a transient developmental scaffold for growth plate maturation', Matrix Biology, vol. 52-54, pp. 363 - 383, http://dx.doi.org/10.1016/j.matbio.2016.01.008
2016
Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J, 2016, 'Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis', Arthritis and Rheumatology, vol. 68, pp. 868 - 879, http://dx.doi.org/10.1002/art.39529
2016
Chang T; Trench D; Putnam J; Stenzel MH; Lord MS, 2016, 'Curcumin-Loading-Dependent Stability of PEGMEMA-Based Micelles Affects Endocytosis and Exocytosis in Colon Carcinoma Cells', Molecular Pharmaceutics, vol. 13, pp. 924 - 932, http://dx.doi.org/10.1021/acs.molpharmaceut.5b00820
2016
Lord MS; Cheng B; Tang F; Lyons JG; Rnjak-Kovacina J; Whitelock JM, 2016, 'Bioengineered human heparin with anticoagulant activity', Metabolic Engineering, vol. 38, pp. 105 - 114, http://dx.doi.org/10.1016/j.ymben.2016.07.006
2016
Rnjak-Kovacina J; Tang F; Whitelock JM; Lord MS, 2016, 'Silk biomaterials functionalized with recombinant domain V of human perlecan modulate endothelial cell and platelet interactions for vascular applications', Colloids and Surfaces B: Biointerfaces, vol. 148, pp. 130 - 138, http://dx.doi.org/10.1016/j.colsurfb.2016.08.039
2016
Hayes AJ; Shu CC; Lord MS; Little CB; Whitelock JM; Melrose J, 2016, 'Pericellular colocalisation and interactive properties of type VI collagen and perlecan in the intervertebral disc', European Cells and Materials, vol. 32, pp. 40 - 57, http://dx.doi.org/10.22203/eCM.v032a03
2016
An H; Brettle M; Lee T; Heng B; Lim CK; Guillemin GJ; Lord MS; Klotzsch E; Geczy CL; Bryant K; Fath T; Tedla N, 2016, 'Soluble LILRA3 promotes neurite outgrowth and synapses formation through a high-affinity interaction with Nogo 66', Journal of Cell Science, vol. 129, pp. 1198 - 1209, http://dx.doi.org/10.1242/jcs.182006
2016
Farrugia BL; Whitelock JM; O'Grady R; Caterson B; Lord MS, 2016, 'Mast Cells Produce a Unique Chondroitin Sulfate Epitope', Journal of Histochemistry and Cytochemistry: imaging the spectrum of cell biology, vol. 64, pp. 85 - 98, http://dx.doi.org/10.1369/0022155415620649
2016
Lord MS; Farrugia BL; Yan CMY; Vassie JA; Whitelock JM, 2016, 'Hyaluronan coated cerium oxide nanoparticles modulate CD44 and reactive oxygen species expression in human fibroblasts', Journal of Biomedical Materials Research - Part A, vol. 104, pp. 1736 - 1746, http://dx.doi.org/10.1002/jbm.a.35704
2016
Nandakumar D; Bendavid A; Martin PJ; Harris KD; Ruys AJ; Lord MS, 2016, 'Fabrication of Semiordered Nanopatterned Diamond-like Carbon and Titania Films for Blood Contacting Applications', ACS Applied Materials and Interfaces, vol. 8, pp. 6802 - 6810, http://dx.doi.org/10.1021/acsami.5b11614
2016
Chang T; Gosain P; Stenzel MH; Lord MS, 2016, 'Drug-loading of poly(ethylene glycol methyl ether methacrylate) (PEGMEMA)-based micelles and mechanisms of uptake in colon carcinoma cells', Colloids and Surfaces B: Biointerfaces, vol. 144, pp. 257 - 264, http://dx.doi.org/10.1016/j.colsurfb.2016.04.019
2016
Farrugia BL; Chandrasekar K; Johnson L; Whitelock JM; Marks D; Irving D; Lord M, 2016, 'Perspectives on the use of biomaterials to store platelets for transfusion', Biointerphases: an open access journal for the biomaterials interface community, vol. 11, pp. 029701 - 029701, http://dx.doi.org/10.1116/1.4952450
2016
Lord M; Chuang C; Rnjak‐Kovacina J; Cheng B; Lyons G; Whitelock J, 2016, 'Bioengineering Proteoglycan‐based Matrices For Blood Contacting Applications', The FASEB Journal, vol. 30, http://dx.doi.org/10.1096/fasebj.30.1_supplement.622.2
2016
Lord MS; Farrugia BL; Rnjak-Kovacina J; Whitelock JM, 2015, 'Current serological possibilities for the diagnosis of arthritis with special focus on proteins and proteoglycans from the extracellular matrix', Expert Review of Molecular Diagnostics, vol. 15, pp. 77 - 95, http://dx.doi.org/10.1586/14737159.2015.979158
2015
Farrugia BL; Lord MS; Melrose J; Whitelock JM, 2015, 'Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?', Molecules, vol. 20, pp. 4254 - 4276, http://dx.doi.org/10.3390/molecules20034254
2015
Chrzanowski W; Lee JH; Kondyurin A; Lord MS; Jang JH; Kim HW; Bilek MMM, 2015, 'Nano-Bio-Chemical Braille for Cells: The Regulation of Stem Cell Responses using Bi-Functional Surfaces', Advanced Functional Materials, vol. 25, pp. 193 - 205, http://dx.doi.org/10.1002/adfm.201401696
2015
Chen Y; Lord MS; Piloni A; Stenzel MH, 2015, 'Correlation between molecular weight and branch structure of glycopolymers stars and their binding to lectins', Macromolecules, vol. 48, pp. 346 - 357, http://dx.doi.org/10.1021/ma501742v
2015
Shawky MS; Ricciardelli C; Lord M; Whitelock J; Ferro V; Britt K; Thompson EW, 2015, 'Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk', Journal of Mammary Gland Biology and Neoplasia, vol. 20, pp. 121 - 131, http://dx.doi.org/10.1007/s10911-015-9346-z
2015
Chrzanowski W; Lee JH; Kondyurin A; Lord MS; Jang J-H; Kim H-W; Bilek MMM, 2015, 'Biointerfaces: Nano-Bio-Chemical Braille for Cells: The Regulation of Stem Cell Responses using Bi-Functional Surfaces (Adv. Funct. Mater. 2/2015)', Advanced Functional Materials, vol. 25, pp. 339 - 339, http://dx.doi.org/10.1002/adfm.201570014
2015
Lord MS; Chuang CY; Melrose J; Davies MJ; Iozzo RV; Whitelock JM, 2014, 'The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling', Matrix Biology, vol. 35, pp. 112 - 122, http://dx.doi.org/10.1016/j.matbio.2014.01.016
2014
Lord MS; Tsoi BM; Farrugia BL; Simon Ting SR; Baker S; Wiesmann WP; Whitelock JM, 2014, 'Synthesis and characterization of water soluble biomimetic chitosans for bone and cartilage tissue regeneration', Journal of Materials Chemistry B, vol. 20, pp. 6517 - 6526, http://dx.doi.org/10.1039/c4tb00531g
2014
Chang T; Lord MS; Bergmann B; MacMillan A; Stenzel MH, 2014, 'Size effects of self-assembled block copolymer spherical micelles and vesicles on cellular uptake in human colon carcinoma cells', Journal of Materials Chemistry B, vol. 2, pp. 2883 - 2891, http://dx.doi.org/10.1039/c3tb21751e
2014
Lord MS; Jung MS; Cheng B; Whitelock JM, 2014, 'Transcriptional complexity of the HSPG2 gene in the human mast cell line, HMC-1', Matrix Biology, vol. 35, pp. 123 - 131, http://dx.doi.org/10.1016/j.matbio.2013.12.005
2014
Lord MS; Whitelock JM; Simmons A; Williams RL; Milthorpe BK, 2014, 'Fibrinogen adsorption and platelet adhesion to silica surfaces with stochastic nanotopography', Biointerphases, vol. 9, pp. 041002, http://dx.doi.org/10.1116/1.4900993
2014
2014, 'Bioengineered heparin: Is there a future for this form of the successful therapeutic?', Bioengineered, vol. 5, pp. 222 - 226, http://dx.doi.org/10.4161/bioe.29388
2014
Farrugia BL; Whitelock JM; Jung M; O'Grady RL; McGrath B; McCarthy SJ; Lord MS, 2014, 'The localisation of inflammatory cells and expression of associated proteoglycans in response to implanted chitosan', Biomaterials, vol. 35, pp. 1462 - 1477, http://dx.doi.org/10.1016/j.biomaterials.2013.10.068
2014
Zhao Y; Lord MS; Stenzel MH, 2013, 'A polyion complex micelle with heparin for growth factor delivery and uptake into cells', Journal of Materials Chemistry, vol. 1, pp. 1635 - 1643, http://dx.doi.org/10.1039/c3tb00360d
2013
Ting SRS; Whitelock J; Tomic R; Gunawan C; Teoh WY; Amal R; Lord MS, 2013, 'Cellular uptake and activity of heparin functionalised cerium oxide nanoparticles in monocytes', Biomaterials, vol. 34, pp. 4377 - 4386, http://dx.doi.org/10.1016/j.biomaterials.2013.02.042
2013
Lord MS; Tsoi BM; Gunawan C; Teoh WY; Amal R; Whitelock J, 2013, 'Anti-Angiogenic Activity of Heparin Functionalised Cerium Oxide Nanoparticles', Biomaterials, vol. 34, pp. 8808 - 8818, http://dx.doi.org/10.1016/j.biomaterials.2013.07.083
2013
Jung M; Lord MS; Cheng B; Lyons JG; Alkouri H; Hughes M; McCarthy S; Iozzo R; Whitelock J, 2013, 'Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: A role in angiogenesis and wound healing', The Journal of Biological Chemistry, vol. 288, pp. 3289 - 3304, http://dx.doi.org/10.1074/jbc.M112.387811
2013
Lord MS; Day AJ; Youssef P; Zhuo L; Watanabe H; Caterson B; Whitelock J, 2013, 'Sulfation of the bikunin chondroitin sulfate chain determines heavy chain-hyaluronan complex formation', The Journal of Biological Chemistry, vol. 288, pp. 11941 - 22930, http://dx.doi.org/10.1074/jbc.M112.404186
2013
Reyes-ortega F; Rodriguez G; Aguilar MR; Lord MS; Whitelock J; Stenzel MH; San Roman J, 2013, 'Encapsulation of low molecular weight heparin (bemiparin) into polymeric nanoparticles obtained from cationic block copolymers: Properties and cell activity', Journal of Materials Chemistry, vol. 1, pp. 850 - 860, http://dx.doi.org/10.1039/c2tb00194b
2013
Lord MS; Whitelock J, 2013, 'Recombinant production of proteoglycans and their bioactive domains', FEBS Journal, vol. 280, pp. 2490 - 2510, http://dx.doi.org/10.1111/febs.12197
2013
Lord MS; Jung M; Teoh WY; Gunawan C; Vassie JA; Amal R; Whitelock J, 2012, 'Cellular uptake and reactive oxygen species modulation of cerium oxide nanoparticles in human monocyte cell line U937', Biomaterials, vol. 33, pp. 7915 - 7924, http://dx.doi.org/10.1016/j.biomaterials.2012.07.024
2012
Decarlo AA; Belousova A; Ellis AL; Petersen D; Grenett H; Hardigan P; O''Grady R; Lord MS; Whitelock J, 2012, 'Perlecan domain 1 recombinant proteoglycan augments BMP-2 activity and osteogenesis', BMC Biotechnology, vol. 12, pp. 60 - 60, http://dx.doi.org/10.1186/1472-6750-12-60
2012
Chrzanowski W; Kondyurin A; Lee JH; Lord MS; Bilek MMM; Kim H-W, 2012, 'Biointerface: protein enhanced stem cells binding to implant surface', Journal of Materials Science - Materials in Medicine, vol. 23, pp. 2203 - 2215, http://dx.doi.org/10.1007/s10856-012-4687-2
2012
Chuang CY; Shahin K; Lord MS; Melrose J; Doran PM; Whitelock J, 2012, 'The cartilage matrix molecule components produced by human foetal cartilage rudiment cells within scaffolds and the role of exogenous growth factors', Biomaterials, vol. 33, pp. 4078 - 4088, http://dx.doi.org/10.1016/j.biomaterials.2012.02.032
2012
Lord MS; Estrella RP; Chuang CY; Youssef P; Karlsson NG; Flannery CR; Whitelock J, 2012, 'Not all lubricin isoforms are substituted with a glycosaminoglycan chain', Connective Tissue Research, vol. 53, pp. 132 - 141, http://dx.doi.org/10.3109/03008207.2011.614364
2012
Lord MS; Cheng B; McCarthy S; Jung M; Whitelock J, 2011, 'The modulation of platelet adhesion and activation by chitosan through plasma and extracellular matrix proteins', Biomaterials, vol. 32, pp. 6655 - 6662, http://dx.doi.org/10.1016/j.biomaterials.2011.05.062
2011
Hayes AJ; Lord MS; Smith SM; Smith MM; Whitelock JM; Weiss AS; Melrose J, 2011, 'Colocalization in vivo and association in vitro of perlecan and elastin', Histochemistry and Cell Biology, vol. 136, pp. 437 - 454, http://dx.doi.org/10.1007/s00418-011-0854-7
2011
Inglis D; Lord MS; Nordon R, 2011, 'Scaling deterministic lateral displacement arrays for high throughput and dilution-free enrichment of leukocytes', Journal of Micromechanics and Microengineering, vol. 21, pp. 054024, http://dx.doi.org/10.1088/0960-1317/21/5/054024
2011
Holst J; Watson S; Lord MS; Eamegdool SS; Bax DV; Nivison-Smith LB; Kondyurin A; Ma L; Overhauser AF; Weiss AS; Rasko JEJ, 2010, 'Substrate elasticity provides mechanical signals for the expansion of hemopoietic stem and progenitor cells', Nature Biotechnology, vol. 28, pp. 1123 - 1130, http://dx.doi.org/10.1038/nbt.1687
2010
Lord MS; Foss M; Besenbacher F, 2010, 'Influence of nanoscale surface topography on protein adsorption and cellular response', Nano Today, vol. 5, pp. 66 - 78, http://dx.doi.org/10.1016/j.nantod.2010.01.001
2010
Chuang CY; Lord MS; Melrose J; Rees MD; Knox SM; Freeman C; Iozzo R; Whitelock J, 2010, 'Heparan sulfate-dependent signaling of fibroblast growth factor 18 by chondrocyte-derived perlecan', Biochemistry, vol. 49, pp. 5524 - 5532, http://dx.doi.org/10.1021/bi1005199
2010
Lord MS; Yu W; Cheng B; Simmons A; Poole-Warren LA; Whitelock J, 2009, 'The modulation of platelet and endothelial cell adhesion to vascular graft materials by perlecan', Biomaterials, vol. 30, pp. 4898 - 4906, http://dx.doi.org/10.1016/j.biomaterials.2009.05.063
2009
Lord MS; Pasqui D; Barbucci R; Milthorpe BK, 2009, 'Protein adsorption on derivatives of hyaluronic acid and subsequent cellular response', Journal of Biomedical Materials Research Part A, vol. 91, pp. 635 - 646, http://dx.doi.org/10.1002/jbm.a.32219
2009
Whitelock J; Ma J; Davies NP; Nielsen N; Chuang CY; Rees MR; Iozzo R; Knox SM; Lord MS, 2008, 'Recombinant heparan sulfate for use in tissue engineering applications', Journal of Chemical Technology and Biotechnology, vol. 83, pp. 496 - 504, http://dx.doi.org/10.1002/jctb.1835
2008
Lord MS; Modin C; Foss M; Duch M; Simmons A; Pedersen F; Besenbacher F; Milthorpe BK, 2008, 'Extracellular matrix remodelling during cell adhesion monitored by the quartz crystal microbalance', Biomaterials, vol. 29, pp. 2581 - 2587, http://dx.doi.org/10.1016/j.biomaterials.2008.03.002
2008
Melrose J; Roughley P; Knox SM; Smith S; Lord MS; Whitelock J, 2006, 'The structure, location and function of perlecan, a prominent pericellular proteoglycan of foetal, postnatal and mature hyaline cartilages', The Journal of Biological Chemistry, vol. 281, pp. 36905 - 36914, http://dx.doi.org/10.1074/jbc.M608462200
2006
Lord MS; Stenzel M; Simmons A; Milthorpe BK, 2006, 'The effect of charged groups on protein interactions with poly(HEMA) hydrogels', Biomaterials, vol. 27, pp. 567 - 575, http://dx.doi.org/10.1016/j.biomaterials.2005.06.010
2006
Lord MS; Cousins B; Doherty P; Whitelock J; Simmons A; Williams R; Milthorpe BK, 2006, 'The effect of silica nanoparticulate coatings on serum protein adsorption and cellular response', Biomaterials, vol. 27, pp. 4856 - 4862, http://dx.doi.org/10.1016/j.biomaterials.2006.05.037
2006
Lord MS; Modin C; Foss M; Duch M; Simmons A; Pedersen F; Milthorpe BK; Besenbacher F, 2006, 'Monitoring cell adhesion on tantalum and oxidised polystyrene using a quartz crystal microbalance with dissipation', Biomaterials, vol. 27, pp. 4529 - 4537, http://dx.doi.org/10.1016/j.biomaterials.2006.04.006
2006
Lord MS; Stenzel M; Simmons A; Milthorpe BK, 2006, 'Lysozyme interaction with poly(HEMA)-based hydrogel', Biomaterials, vol. 27, pp. 1341 - 1345, http://dx.doi.org/10.1016/j.biomaterials.2005.09.007
2006
Conference Papers
add
Johnson BB; Holmes TL; Thompson JL; Lord M; Denning C; Whitelock J; Merry CLR; Smith J, 2021, 'A CRISPR/Cas9 in vitro human-induced pluripotent stem cell (hiPSC) model to investigate the role of perlecan in cardiovascular fibrotic disease', in INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, WILEY, pp. 126 - 127, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000630872200029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2021
Tedla N; An H; Fath T; Lord M; Bryant K, 2017, 'Leukocyte immunoglobulin-like receptor A3 (LILRA3) displays anti-inflammatory and neuro-regenerative functions through interaction with multiple ligands', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, Washington, DC, presented at Annual Meeting of the American-Association-of-Immunologists (AAI), Washington, DC, 12 May 2017 - 16 May 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407757000578&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2017
Palmer JC; Lord MS; Pinyon JL; Wise AK; Lovell NH; Carter PM; Enke YL; Housley GD; Green RA, 2016, 'Understanding the cochlear implant environment by mapping perilymph proteomes from different species', in Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS, pp. 5237 - 5240, http://dx.doi.org/10.1109/EMBC.2016.7591908
2016
Langtry TN; Giokaris P; Milthorpe BK; Lord MS, 2013, 'Parameter estimation for a model of fibronectin adsorption onto hydroxylapatite, oxidised polystyrene and nanostructured silica', in Roberts AJ (ed.), ANZIAM Journal, pp. C429 - C445, http://journal.austms.org.au/ojs/index.php/ANZIAMJ/article/view/6326
2013
Lord MS; Pasqui D; Barbucci R; Milthorpe BK, 2008, 'Protein adsorption on derivatives of hyaluronan', in Macromolecular Symposia, Wiley-V C H Verlag Gmbh, pp. 17 - 22, http://dx.doi.org/10.1002/masy.200850604
2008
Lord MS; Modin C; Foss M; Duch M; Simmons A; Besenbacher F; Milthorpe BK, 2005, 'Investigation of cellular interactions with surfaces using the quartz crystal microbalance (QCM-D)', in x (ed.), Proceedings of the 7th International Conference of Cellular Engineering, 7th International Conference of Cellular Engineering, pp. 70 - 73, presented at 7th International Conference of Cellular Engineering, -
2005
Other
add
Reijmers RM; Troeberg L; Lord MS; Petrey AC, 2020, Editorial: Proteoglycans and Glycosaminoglycan Modification in Immune Regulation and Inflammation, http://dx.doi.org/10.3389/fimmu.2020.595867
2020
Conference Abstracts
add
Elgundi Z; Freelander A; Bean P; Whitelock J; Lord M, 2018, 'Investigating the roles of perlecan using antibodies with unique epitopes', in INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, WILEY, Manchester, ENGLAND, Vol. 99, pp. A23 - A23, presented at Matrix Biology Europe Meeting, Manchester, ENGLAND, 21 July 2018 - 24 July 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000459467900046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Smith J; Merry C; Lord M; Denning C; Whitelock J, 2018, 'Developing an in vitro human induced pluripotent stem cell (hiPSC) model using CRISPR/Cas9 to investigate the role of perlecan in fibrosis', in INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, WILEY, Manchester, ENGLAND, Vol. 99, pp. A20 - A21, presented at Matrix Biology Europe Meeting, Manchester, ENGLAND, 21 July 2018 - 24 July 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000459467900041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Johnson L; Farrugia B; Whitelock J; Marks DC; Irving DO; Lord M, 2018, 'Biomimetic Surface Modification of PVC Platelet Bags to Improve Platelet Storage', in TRANSFUSION, WILEY, Boston, MA, Vol. 58, pp. 147A - 147A, presented at AABB Annual Meeting, Boston, MA, 13 October 2018 - 16 October 2018, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000444475900342&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2018
Lord M; chuang C; rnjak-kovacina J; cheng B; lyons G; whitelock J, 2016, 'Bioengineering proteoglycan-based matrices for blood contacting applications', in The FASEB Journal, Federation of American Society of Experimental Biology (FASEB), San Diego, Vol. 6, pp. 622.2 - 622.2, presented at Experimental Biology 2016, San Diego, 02 April 2016 - 06 April 2016
2016
Rnjak-Kovacina J; Tang F; Whitelock JM; Lord MS, 2016, 'Domain V of Perlecan Covalently Immobilized on Silk Biomaterials Modulates Endothelial Cell and Platelet Interactions for Vascular Applications', in TISSUE ENGINEERING PART A, MARY ANN LIEBERT, INC, San Diego, CA, Vol. 22, pp. S20 - S21, presented at TERMIS - Americas Conference and Exhibition, San Diego, CA, 11 December 2016 - 14 December 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000390569200074&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2016
Tang F; Lau K; Kondyurin A; Lord MS; Whitelock JM; Bilek MM; Rnjak-Kovacina J, 2016, 'Plasma Immersion Ion Implantation Treatment of Silk Biomaterials Enhances Biological Function', in Plasma Immersion Ion Implantation Treatment of Silk Biomaterials Enhances Biological Function, TISSUE ENGINEERING PART A, San Diego, Vol. 22, pp. S129 - S129, presented at TISSUE ENGINEERING PART A, San Diego, 11 December 2016 - 14 December 2016
2016
Farrugia BL; Whitelock J; Lord M, 2016, 'CHITOSAN SULPHATE: ENGINEERING A BIOMIMETIC GROWTH FACTOR DELIVERY SYSTEM', in Wound Repair and Regeneration, Wiley, Melbourne, Australia, Vol. 24, pp. A13 - A30, presented at Joint meeting of the Australasian Wound and Tissue Repair Society (AWTRS) and the Molecular & Experimental Pathology Society of Australasia (MEPSA), Melbourne, Australia, 07 November 2016 - 09 November 2016, http://dx.doi.org/10.1111/wrr.12489
2016
Lord M; Whitelock J; Cheng B; Tang F; Lyons G, 2016, 'Bioengineering of human heparin: A next generation anti-coagulant', in The FASEB Journal, Federation of American Society of Experimental Biology (FASEB), San Diego, Vol. 30, pp. 1070.5 - 1070.5, presented at Experimental Biology 2016 Meeting, San Diego, 02 April 2016 - 06 April 2016
2016
Farrugia BL; Whitelock J; LORD M, 2016, 'The inflammatory response to implanted materials, fibrous capsule characterisation', in Front. Bioeng. Biotechnol., 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016., presented at 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016., http://dx.doi.org/10.3389/conf.FBIOE.2016.01.00994
2016
Farrugia BL; whitelock J; LORD M, 2016, 'Chitosan sulfate: engineering a biomimetic growth factor delivery system', in Front. Bioeng. Biotechnol., WILEY-BLACKWELL, Vol. 24, pp. A18 - A18, presented at 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016, http://dx.doi.org/10.3389/conf.FBIOE.2016.01.01019
2016
Gunatillake T; Chui A; Lord M; Whitelock J; Murthi P; Ignatovic V; Monagle P; Brennecke S; Said J, 2015, '[289-POS]: Placental heparan sulphate glycosaminoglycans in pre-eclampsia.', in Pregnancy Hypertens, Netherlands, Vol. 5, pp. 144, Netherlands, http://dx.doi.org/10.1016/j.preghy.2014.10.295
2015
Whitelock J; Jung M; Cheng B; Lord M, 2014, 'Transcriptional regulation and proteolytic processing of perlecan in mast cells lead to the production of forms that contain the alpha2/beta1 integrin binding site: roles in wound healing and tissue regeneration', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, San Diego, CA, Vol. 28, presented at Experimental Biology Meeting, San Diego, CA, 26 April 2014 - 30 April 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346646701331&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2014
Penm S; Lord MS; O'Grady R; Whitelock J, 2012, 'Expression of matrix components in liver cells: Studies in human hepatocytes (HepG2) and hepatic stellate cells (LX-2)', in Glycobiology, Vol. 22, pp. 1546 - 1547, http://dx.doi.org/10.1093/glycob/cws127
2012
Tang F; Lord M; Whitelock J, (ed.), 2012, 'The roles of melanoma-associated protein (CSPG4) and perlecan (HSPG2) in cancer, potential targets for drug therapy', in Glycobiology, OXFORD UNIV PRESS INC, San Diego, CA, Vol. 22, pp. 1605 - 1605, presented at Joint Meeting of the Society-for-Glycobiology and American-Society-for-Matrix-Biology, San Diego, CA, 11 - 14 November 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310368700259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
2012
Jung M; Lord M; Cheng B; Lyons JG; Alkhouri H; Hughes JM; McCarthy S; Iozzo R; Whitelock J, 2012, 'Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: A role in angiogenesis and wound healing', in GLYCOBIOLOGY, OXFORD UNIV PRESS INC, San Diego, CA, Vol. 22, pp. 1627 - 1628, presented at Joint Meeting of the Society-for-Glycobiology and American-Society-for-Matrix-Biology, San Diego, CA, 11 November 2012 - 14 November 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310368700326&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Jung M; Lord M; Cheng B; Lyons J; McCarthy S; Iozzo R; Whitelock J, 2012, 'MAST CELLS PRODUCE SHORTER FORMS OF PERLECAN THAT CONTAIN ENDOREPELLIN AND PROMOTE TISSUE FIBROSIS', in WOUND REPAIR AND REGENERATION, WILEY-BLACKWELL, Vol. 20, pp. A69 - A69, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308945000066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Penm S; Lord M; O'Grady R; Whitelock J, 2012, 'Expression of matrix components in liver cells: Studies in human hepatocytes (HepG2) and hepatic stellate cells (LX-2)', in GLYCOBIOLOGY, OXFORD UNIV PRESS INC, San Diego, CA, Vol. 22, pp. 1546 - 1547, presented at Joint Meeting of the Society-for-Glycobiology and American-Society-for-Matrix-Biology, San Diego, CA, 11 November 2012 - 14 November 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310368700089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Lord M; Day A; Youssef P; Zhuo L; Watanabe H; Caterson B; Whitelock J, 2012, 'Chondroitin sulfate-mediated stabilization of hyaluronan-rich matrices', in GLYCOBIOLOGY, OXFORD UNIV PRESS INC, San Diego, CA, Vol. 22, pp. 1627 - 1627, presented at Joint Meeting of the Society-for-Glycobiology and American-Society-for-Matrix-Biology, San Diego, CA, 11 November 2012 - 14 November 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310368700324&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Whitelock JM; Jung MS; Chuang CY; Cheng B; Koo T; Lyons JG; Lord MS, 2012, 'Shorter forms of the proteoglycan, Perlecan; Adding complexity to an already complex molecule', in FASEB JOURNAL, FEDERATION AMER SOC EXP BIOL, San Diego, CA, Vol. 26, presented at Experimental Biology Meeting, San Diego, CA, 21 April 2012 - 25 April 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310711305959&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2012
Whitelock J; Jung MS; McCarthy S; So R; Lord M, 2010, 'ENZYMATIC PROCESSING OF EXTRACELLULAR MATRIX HEPARAN SULFATE PROTEOGLYCANS IN WOUND HEALING: A ROLE FOR MAST CELLS?', in WOUND REPAIR AND REGENERATION, WILEY-BLACKWELL, Vol. 18, pp. A61 - A61, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000279454700012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2010
Milthorpe B; Lord M; Simmons A, 2008, 'Cell-material interactions from modeling QCM-D data', in 8th World Biomaterials Congress 2008, Vol. 3, pp. 1236
2008
Lord M; Ma J; Davies N; Chuang C; Nielsen N; Iozzo R; Whitelock J, 2008, 'Modulation of biosignalling using recombinant heparan sulfate', in 8th World Biomaterials Congress 2008, Vol. 3, pp. 1237
2008
Lord MS; Milthorpe BK, 2004, 'A quartz crystal microbalance study of biomolecular adsorption on polymer films', in Transactions - 7th World Biomaterials Congress, pp. 1378
2004
(eds.), 2004, 'Transactions of the 7th World Biomaterials Congress', in Transactions of the 7th World Biomaterials Congress, Transactions of the 7th World Biomaterials Congress, Sydney, presented at Transactions of the 7th World Biomaterials Congress, Sydney
2004
(ed.), 2003, '18th European Conference on Biomaterials', in 18th European Conference on Biomaterials, 18th European Conference on Biomaterials, Stuttgart, Germany, presented at 18th European Conference on Biomaterials, Stuttgart, Germany
2003
Book Chapters
add
Vassie JA; Whitelock JM; Lord MS, 2015, 'Glycosaminoglycan functionalized nanoparticles exploit glycosaminoglycan functions', in Methods in Molecular Biology, pp. 557 - 565, http://dx.doi.org/10.1007/978-1-4939-1714-3_44
2015
Conference Presentations
add
Lord MS; Jung M; Cheng B; McCarthy S; McGrath B; Whitelock J, 2011, 'Chitosan modulates wound healing events through interactions with platelets and mast cells', presented at The Australasian Society for Biomaterials and Tissue Engineering, Queenstown, 26 April 2011 - 30 April 2011
2011

UNSW Faculty of Engineering Excellence in Leadership award (2020)
NSW Young Tall Poppy Science Award in recognition of the achievements of Australia’s outstanding young scientific researchers and communicators. (2014)
UNSW Emeritus Professor Maria Skyllas-Kazacos Young Professional Award for Outstanding Achievement Award for female alumni from UNSW Engineering in recognition of a significant achievement in their field. (2013)
Finalist in the Scopus Young Scientist of the Year Awards, Engineering and Technology Category. (2011)
Trans-continental award for a young scientist from the Federation of European Biochemical Societies. (2011)
New Investigator Award from the Matrix Biology Society of Australia and New Zealand recognised the research achievements of early career researchers in the field of matrix biology with less than 10 years post-doctoral experience. (2008)
UNSW Early Career Researcher Travel Award supported attendance at an international conference. (2007)
COST Action 537 Early Career Research Short Term Scientific Mission Award. European initiative that identified emerging researchers with a capacity for independent research in areas with direct health outcomes. (2007)
Australasian Society for Biomaterials and Tissue Engineering International Travel Award. Society award for travel to international collaborator laboratory. (2006)
Joan Waugh Scholarship. Award from Tara Anglican School for Girls Old Girls' Association for excellence in chosen field and supported doctoral studies. (2004)
Boehringer Ingelheim Fonds Award. Supported international laboratory research visits to expand research skills and build collaborations. (2003)

 

Australian Research Council Linkage Project with Synedgen Inc (2020-2023) Understanding glycopolymer interactions with the extracellular matrix.
Diabetes Australia General Grant (2019) Bioengineered growth factor binding scaffolds.
Australian Research Council Linkage Infrastructure, Equipment and Facilities (2019) Advanced mechanical property testing suite.
Australian Research Council Discovery Project (2015-2019) Novel biomimetic vascular biomaterials using extracellular matrix molecules.
Australian Research Council Linkage Project with the Australian Red Cross Blood Service (2014-2019) Biomimetic blood bag materials for prolonged platelet storage.
Australian Research Council Linkage Project with Cochlear Ltd (2014-2018) Biological determinants of the safety and stability of neuroprosthetic stimulation electrodes.
National Heart Foundation (2011-2012) The roles of perlecan heparan sulphate in modulating vascular intimal hyperplasia.
Australian Research Council Linkage Project with Synedgen Inc (including Australian Postdoctoral Fellowship) (2010-2014) Targeted growth factor delivery using natural polysaccharide materials for bone regeneration.
Australian Research Council Discovery Project (2010-2013) Advanced nanoparticles as biocompatible antioxidant agents with targeting functionality.
Australian Research Council Linkage Project with HemCon Medical Technologies (2007-2010) Blood component interactions with polysaccharide biomaterials for vascular applications.

In addition, Associate Professor Lord has been awarded grant funding from UNSW through the Research Infrastructure Scheme, Career Advancement Fund, Faculty of Engineering Carers Award, Faculty of Engineering Early Career Researcher fund and School project support.

  • Protein and cell interactions with biomaterials
  • Biophysical analyses of molecular interactions
  • Extracellular matrix molecule biochemistry and biomaterials application
  • Biomimetic biomaterials for blood-contacting and tissue vascularisation applications using in vitro and in vivo models.

 

Cellular and Tissue Engineering (BIOM9333)
Research Thesis (BIOM4951/4952/4953)
Research Thesis Biomedical Engineering (BIOM9020/9021)